Risk factors for cardiovascular disease in children on chronic hemodialysis – Uremia-related (non-traditional) risk factors, part II

Ljiljana S Šulović

doi:10.2298/VSP150418144S

Ljiljana S Šulović Department of Cardiology, Children's Hospital, Faculty of Medicine, University of Priština/Kosovska Mitrovica, Kosovska Mitrovica, Serbia

DOI: https://doi.org/10.2298/VSP150418144S

Keywords: renal insufficiency, chronic, cardiovascular diseases, risk factors, renal dialysis, child,

References

Staples AO, Wong CS, Smith JM, Gipson DS, Filler G, Warady BA, et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(1): 48−56.

Mitsnefes MM. Cardiovascular Disease in Children with Chronic Kidney Disease. J Am Soc Nephrol 2012; 23(4): 578−85.

Warady BA, Ho M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 2003; 18(10): 1055−62.

White CT, Schisler T, Er L, Djurdjev O, Matsuda-Abedini M. CKD following kidney transplantation in children and adolescents. Am J Kidney Dis 2008; 51(6): 996−1004.

Cengiz N, Baskin E, Agras PI, Sezgin N, Saatci U. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis. Transplant Proc 2005; 37(7): 2915−7.

Šulović N, Šulović LJ, Relić G. Uticaj malnutricije na aktivaciju preterminskog porođaja i prostaglandinskog puta. Praxis medica 2014; 43(2): 61−4. (Serbian)

Goldstein SL, Leung JC, Silverstein DM. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: Effect of aspirin. Clin J Am Soc Nephrol 2006; 1(5): 979−86.

Panichi V, Migliori M, de Pietro S, Taccola D, Bianchi AM, Norpoth M, et al. C reactive protein in patients with chronic renal fail-ure. Ren Fail 2001; 23(3−4): 551−62.

Tirmenštajn-Janković B, Bastać D. Use of cardiac biomarkers for diagnosis and prognosis of cardiovascular events in patients with chronic kidney disease. Glasilo Podružnice Srpskog le-karskog društva Zaječar; 2009; 34(3−4): 169−77. (Serbian)

Djelic M, Cabarkapa VS. Cardiovascular biomarkers in chronic kidney disease. J Med Biochem 2010; 29(4): 298−303.

Miric D, Kisic B, Stolic R, Miric B, Mitic R, Janicijevic-Hudomal S. The Role of Xanthine Oxidase in Hemodialysis-Induced Oxi-dative Injury: Relationship with Nutritional Status. Oxid Med Cell Longev 2013; 2013: 245253.

Rinat C, Becker-Cohen R, Nir A, Feinstein S, Algur N, Ben-Shalom E, et al. B-type natriuretic peptides are reliable markers of car-diac strain in CKD pediatric patients. Pediatr Nephrol 2012; 27(4): 617−25.

Shroff R, Weaver DJ, Mitsnefes M. Cardiovascular complications in children with chronic kidney disease. Nat Rev Nephrol 2011; 7(11): 642−9.

Cengiz N, Baskin E, Sezgin N, Agras P, Haberal M. Oxidative stress in children on hemodialysis: Value of autoantibodies against oxidized low-density lipoprotein. Pediatr Nephrol 2009; 24(2): 387−93.

Mitsnefes MM, Kartal J, Khoury PR, Daniels SR. Adiponectin in Children with Chronic Kidney Disease: Role of Adiposity and Kidney Dysfunction. Clin J Am Soc Nephrol 2007; 2(1): 46−50.

Lo MM, Salisbury S, Scherer PE, Furth SL, Warady BA, Mitsnefes MM. Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol 2011; 26(11): 2009−17.

Adamczak M, Szotowska M, Chudek J, Karkoszka H, Cierpka L, Wieçek A. Plasma adiponectin concentration in patients after successful kidney transplantation: A single-center, observa-tional study. Clin Nephrol 2007; 67(6): 381−90.

Bek K, Akman S, Bilge I, Topaloğlu R, Calişkan S, Peru H, et al. Chronic kidney disease in children in Turkey. Pediatr Nephrol 2009; 24(4): 797−806.

Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus me-tabolism. J Am Soc Nephrol 2005; 16(9): 2796−803.

Petrović D, Stojimirović B. Secondary hyperparathyroidism-risk factor for development of cardiovascular complications in pa-tients on hemodialysis. Med Pregl 2010; 63(9−10): 674−80. (Serbian)

Wilson AC, Greenbaum LA, Barletta GM, Chand D, Lin J, Patel HP, et al. High prevalence of the metabolic syndrome and as-sociated left ventricular hypertrophy in pediatric renal trans-plant recipients. Pediatr Transplant 2010; 14(1): 52−60.

Shroff R, Weaver D, Mitsnefes M. Cardiovascular complications in children with chronic kidney disease. Nat Rev Nephrol 2011; 7(11): 642−9.

Registry ERA-EDTA. ERA-EDTA Registry Annual Report 2008. Amsterdam, Netherlands: Academic Medical Center, Department of Medical Informatics; 2010.

Šulović LJ. Cardiovascular complications in children on chronic hemodialysis, 1st ed.. Niš: M COPS CENTAR. 2013. (Serbian)

Šulović LJ. Is hypertension, in children who are on chronic he-modialysis therapy, crucial for the development of cardiac hy-pertrophy. Praxis medica 2016; 44(1):15-7. (In press) (Serbian)

Šulović LJ. Non-invasive assessment of cardiac function in children on chronic hemodialysis [dissertation]. Kosovska Mi-trovica: School of Medicine; 2008. (Serbian)

Šulović LJ, Šulović N. Tissue Doppler. Praxis medica 2012; 41(3−4): 92−7. (Serbian)

Djukic M, Jovanovic I, Sulovic LJ, Stefanovic I, Dabetic M, Ilisic T. Estimation of left ventricular filling pressure in children on hemodyalisis. 5th World Congress of Paediatric Cardiology and Cardiac Surgery; 2009 June 21−26; Queensland, Australia: Cairns Convention Center; 2009.